1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceuticals in Asia-Pacific

Pharmaceuticals in Asia-Pacific

  • September 2016
  • -
  • MarketLine
  • -
  • 33 pages

Summary
Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Asia-Pacific

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific

Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts

Synopsis
Essential resource for top-line data and analysis covering the Asia-Pacific pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buy
What was the size of the Asia-Pacific pharmaceuticals market by value in 2015?

What will be the size of the Asia-Pacific pharmaceuticals market in 2020?

What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitors in Asia-Pacific's pharmaceuticals market?

Key Highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The Asia-Pacific pharmaceuticals market had total revenues of $276.9bn in 2015, representing a compound annual growth rate (CAGR) of 8.4% between 2011 and 2015.

The Asia-Pacific market has for a long time appeared to be one of the key areas for pharmaceutical growth throughout the world with good reliable growth rates and big potential for development.

The performance of the market is forecast to decelerate, with an anticipated CAGR of 6.4% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $376.9bn by the end of 2020.

Table Of Contents

Pharmaceuticals in Asia-Pacific
Table of Contents
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Daiichi Sankyo Co., Ltd.
Dr. Reddy's Laboratories Limited
Shanghai Pharmaceuticals Holding Co Ltd
Yangtze River Pharmaceutical Group
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

List of Tables
Table 1: Asia-Pacific pharmaceuticals market value: $ billion, 2011-15
Table 2: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2015
Table 3: Asia-Pacific pharmaceuticals market share: % share, by value, 2015
Table 4: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2015-20
Table 5: Daiichi Sankyo Co., Ltd.: key facts
Table 6: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 7: Daiichi Sankyo Co., Ltd.: key financials (Â¥)
Table 8: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 9: Dr. Reddy's Laboratories Limited: key facts
Table 10: Dr. Reddy's Laboratories Limited: key financials ($)
Table 11: Dr. Reddy's Laboratories Limited: key financials (Rs.)
Table 12: Dr. Reddy's Laboratories Limited: key financial ratios
Table 13: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 14: Yangtze River Pharmaceutical Group: key facts

List of Figures
Figure 1: Asia-Pacific pharmaceuticals market value: $ billion, 2011-15
Figure 2: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 3: Asia-Pacific pharmaceuticals market share: % share, by value, 2015
Figure 4: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2015
Figure 6: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2015
Figure 7: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2015
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2015
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2015
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2015
Figure 11: Daiichi Sankyo Co., Ltd.: revenues and profitability
Figure 12: Daiichi Sankyo Co., Ltd.: assets and liabilities
Figure 13: Dr. Reddy's Laboratories Limited: revenues and profitability
Figure 14: Dr. Reddy's Laboratories Limited: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025 Summary Sales of dyslipidemia therapeutics is estimated to be approximately $11.2B across the 7MM in 2015, encompassing the ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.